UCSF Andino Lab
Dr. Raul Andino
Dr. Andino is a leading virologist and visionary in his understanding of viral quasi species. His team together with collaborators from Stanford and the Tauber Bioinformatics Research Institute have developed a new sequencing approach and computational analysis tools. Today, one of Raul’s many hats includes Aleph Therapeutics, a startup company commercializing CirSeq.
We have been working with Pine biotech for a number of years and the service the they provide is critical for the new type of quantitative science that is now critical to understand biological mechanisms. In particularly the statistic analysis, association and integration of diverse data sets is at the core of discovery and understanding of biological processes.